@kriptomuduru.eth
Neuron Gale is tackling Alzheimer’s inflammation with a Galectin-3 inhibitor, now being tested in vivo. A successful readout could unlock massive potential in a $1.44T market.
Team:
Dr. Maryna Polyakova (Foresight Institute)
Dr. Peter Groenen (25+ yrs translational R&D)
@Cerebrum_DAO (onchain brain-health research)
Funded via Bio’s Milestone Funding:
FDV ↑ → funding unlocks.
Initial: $50K → Potential: $1.06M
Milestones: $1M / $2M / $4.2M / $8.6M / $17.7M
Tokenomics:
10% Ignition Sale • 5% veBIO airdrop
20% liquid at TGE • 80% vest over 30 days
Ignition Sale live for 24h.
Join with USDC + BioXP before Nov 21, 11am UTC.
$GALE is live.
https://app.bio.xyz/ipts/neuron-gale
0 reply
0 recast
0 reaction